publication . Article . 2016

Evaluation of lactobacillus probiotics as adjuvants for nasal immunization with chimeric pneumococcal vaccine

G. F. Leontieva; T. A. Kramskaya; K. B. Grabovskaya; V. Yu. Filimonova; J. Laiñ o; J. Villena; S. Alvares; V. N. Danilenko; A. N. Suvorov;
Open Access Russian
  • Published: 01 Sep 2016
  • Publisher: Russian Association of Allergologists and Clinical Immunologists
  • Country: Argentina
Abstract
Vaccine protection against photogenic gram-positive bacteria including different species of streptococci is an important problem of contemporary molecular biology. Streptococcal infections are most common bacterial infections surpassing by the economic losses all the infections excluding influenza. The gates of streptococcal infection, oral cavity or vagina, are covered with immune and non-immune mucosal cells that are the first line of defenses. Subcutaneous immunization not always stimulate the local immunity on mucosal surfaces. On the other hand, mucosal vaccination can provide an appropriate local immune response together with systemic protection. However, ...
Persistent Identifiers
Subjects
free text keywords: Adjuvants, Lactobacillus, Mucosal Vaccines, Pneumococcal Infection, Probiotics, Recombinant Proteins, Salud Ocupacional, Ciencias de la Salud, CIENCIAS MÉDICAS Y DE LA SALUD, lactobacillus, probiotics, recombinant proteins, mucosal vaccines, adjuvants, pneumococcal infection, Immunologic diseases. Allergy, RC581-607, ЛАКТОБАЦИЛЛЫ,ПРОБИОТИКИ,РЕКОМБИНАНТНЫЕ БЕЛКИ,МУКОЗАЛЬНЫЕ ВАКЦИНЫ,АДЪЮВАНТЫ,ПНЕВМОКОККОВАЯ ИНФЕКЦИЯ,LACTOBACILLUS,PROBIOTICS,RECOMBINANT PROTEINS,MUCOSAL VACCINES,ADJUVANTS,PNEUMOCOCCAL INFECTION, Immunology, Pneumococcal vaccine, Lactobacillus, biology.organism_classification, biology, Medicine, business.industry, business
Any information missing or wrong?Report an Issue